Related Experiment Video
Updated: Jun 5, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and
Nam Hyun Kim1, Su-Nam Kim, Yong Kee Kim
1Department of Pharmacology, Kwandong University College of Medicine, Gangneung 210-701, Republic of Korea.
Abstract:
In this study, we investigate the molecular mechanism by which histone deacetylase (HDAC) inhibitors exert anti-invasiveness effect against prostate cancer cells. We first evaluate the growth inhibition effect of HDAC inhibitors in prostate cancer cells, which is accompanied by induction of p21(WAF1) expression and accumulation of acetylated histones. And we found that the migration and invasion of prostate cancer cells is strongly inhibited by treatment with HDAC inhibitors. In parallel, E-cadherin level is highly up-regulated in HDAC inhibitor-treated prostate cancer cells. And siRNA knockdown of E-cadherin significantly diminishes the anti-invasion effect of HDAC inhibitors, indicating that E-cadherin overexpression is one of possible mechanism for anti-invasion effect of HDAC inhibitors. Furthermore, specific downregulation of HDAC1, but not HDAC2, causes E-cadherin expression and subsequent inhibition of cell motility and invasion. Collectively, our data demonstrate that HDAC1 is a major repressive enzyme for E-cadherin expression as well as HDAC inhibitor-mediated anti-invasiveness.
Insights
Histone deacetylase (HDAC) inhibitors reduce prostate cancer cell invasion by increasing E-cadherin. HDAC1 downregulation is key to this anti-invasion effect, highlighting its role in cell motility.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer metastasis involves cell migration and invasion.
- Histone deacetylase (HDAC) inhibitors are investigated for cancer therapy.
- The precise molecular mechanisms of HDAC inhibitors in prostate cancer remain under investigation.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the anti-invasiveness of HDAC inhibitors in prostate cancer.
- To identify specific HDAC enzymes involved in regulating prostate cancer cell invasion.
Main Methods:
- Prostate cancer cell lines were treated with HDAC inhibitors.
- Cell growth inhibition, p21(WAF1) expression, and histone acetylation were assessed.
- Cell migration and invasion assays were performed.
- E-cadherin expression levels were analyzed via Western blot and siRNA knockdown.
- Specific HDAC1 and HDAC2 downregulation was achieved using siRNA.
Main Results:
- HDAC inhibitors inhibited prostate cancer cell growth, induced p21(WAF1) expression, and increased histone acetylation.
- HDAC inhibitors significantly reduced cancer cell migration and invasion.
- E-cadherin expression was markedly upregulated following HDAC inhibitor treatment.
- siRNA-mediated knockdown of E-cadherin attenuated the anti-invasive effects of HDAC inhibitors.
- Specific downregulation of HDAC1, but not HDAC2, led to increased E-cadherin expression and reduced cell motility and invasion.
Conclusions:
- HDAC inhibitors exhibit anti-invasive properties against prostate cancer cells.
- E-cadherin upregulation is a critical mechanism mediating the anti-invasion effects of HDAC inhibitors.
- HDAC1 is identified as a key enzyme repressing E-cadherin expression and is crucial for HDAC inhibitor-induced anti-invasiveness in prostate cancer.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Structure of Cadherins
Cancer Cell Migration through Invadopodia
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...

